The Rag2-γC double knockout (DKO) mouse lacks T, B and NK cells, and allows development of a functional human immune system with human CD34+ hematopoietic stem/progenitor cells
Introduction
The hallmarks of AIDS are high levels of HIV-1 infection, depletion of CD4+ T cells and loss of immunity. The mechanism of HIV-1 immuno-pathogenesis is not clear because human patients are the only host which supports high levels of HIV-1 replication and develops AIDS. Extensive studies have been performed in primate models with either low levels of HIV-1 replication (HIV-1 in chimps) or a different virus (SIV or SHIV in monkeys). [1] [2] [3] HIV-1 fails to infect murine cells due to blocks at multiple steps of the HIV life cycle. The mouse with reconstituted human immune system would be an ideal small animal model for studying HIV-1 infection and pathogenesis. A number of human-mouse chimeric models have been developed, but with only limited success.
The SCID-hu Thy/Liv mouse has an intact human thymus organ, thus allowing investigation of HIV-1 pathogenesis in a human lymphoid organ. [4] [5] [6] However, very low levels of human T cells are detected in the peripheral lymphoid organs or blood. The hu-PBL-SCID mouse supports transient and selective engraftment of xeno-reactive human T cells. 7, 8 Human CD34+ cells transplanted into SCID or NOD/SCID mice lead to generation of mainly human myeloid and B cells in the mouse bone marrow, but inefficient generation of human T cells. 9, 10 When CD34+
human HSC/HSPC are injected directly into the liver of newborn Rag2-γC double knockout (DKO) mice, which lack T, B and NK cells, the newborn liver environment of DKO mice support efficient engraftment and development of a functional human immune system in central and peripheral lymphoid organs. 11, 12 To demonstrate that the DKO-hu HSC mouse can support efficient HIV-1 infection with relevant immuno-pathogenesis, we show that CCR5 and CXCR4, the HIV-1 coreceptors, are both 
Study design
Construction of DKO-hu HSC mice with human CD34+ cells from cord blood or fetal liver:
Human CD34+ cells were isolated from cord blood or fetal liver tissues. 1x10 6 splenocytes or thymocytes were co-cultured with PHA-activated PBMC for 14 days.
13,17

Results and discussion
We transplanted CD34+ HSPC derived from human cord blood or fetal liver into newborn DKO mice intra-hepatically. 11 Between 8 and 33 weeks post transplant, we analyzed human leukocytes in the peripheral blood and lymphoid organs of these DKO-hu HSC mice. Greater than 90% of the transplanted DKO mice have stable engraftment with human CD45+ cells (Fig.   1A ). CD3+CD4+ cells (10-20% of total PBL) were detected in transplanted mice at 14 weeks post transplant (Fig. 1A) . Long-term development of normal T cell subsets (33 weeks post transplant) is also observed in transplanted mice (Fig. 1B) , suggesting maintenance of human HSPC in DKO-hu HSC mice as previously reported. 18, 19 The HIV-1 entry coreceptors CCR5
and CXCR4 are both expressed on human CD4+ T cells (Fig. 1C) . While the levels of CCR5 expressed on human CD4 T cells derived from DKO-hu HSC mice are comparable to that from primary human tissues or cells, a reduced expression of CXCR4 is detected on human CD4 T cells from DKO-hu HSC mice. 20, 21 As in human primary T cells, CD45RO+ T cells predominantly express CCR5, whereas CD45RO-T cells efficiently express CXCR4 (Fig. 1C) .
To test HIV-1 infection of DKO-hu HSC mice in vivo, we first used the NL4-R3A recombinant virus with the R5/X4 dual tropic R3A Env. R3A was transmitted in the patient (IV drug user) with rapid disease progression, and infected both macrophages and T cells. 22 When inoculated with high dose (20,000 IU/mouse) of the NL4-R3A virus, DKO-hu HSC mice showed very high plasma viral loads (200,000-400,000 copies/ml) at 1 week post infection (wpi) and 10,000
For personal use only. on September 24, 2017. by guest www.bloodjournal.org From copies/ml at 2-4 wpi. Interestingly, HIV-1 plasma viremia was still detectable (947 copies/ml) with infectious HIV-1 at 12 wpi ( Fig. 2A and data not shown) . The mock-infected DKO-hu HSC mice or HIV-infected control DKO mice with no human cells showed no detectable HIV-1 genome ( Fig. 2A and Table 1 ). In the infected DKO-hu HSC mice, CD4+ T cell numbers in the blood were significantly depleted at 2, 3, 4 and 12 weeks post infection (Fig. 2B ).
When infected with a lower dose of NL4-R3A (4,000 IU or 1 ng/mouse), HIV-1 replication peaked at 2-3 wpi, correlated with depletion of CD4+ T cells (Fig. 2C) . Viremia decreased to low or undetectable levels in the infected DKO-hu HSC mouse, correlated with an increase of CD4+ T cells (Fig. 2C) . At 19 wpi with no detectable HIV-1 viremia (<500 copies/ml), infectious HIV-1 was recovered from thymocytes, but not from splenocytes or PBMC in the mouse (Fig.   2G ). In the lymphoid organs at 1 wpi, high levels of productive infection were detected in the thymus, spleen and LN (Fig. 2D&2E) . Interestingly, both CD45RO+ and CD45RO-T cells are infected (Fig. 2D) as in HIV-infected lymphoid organs. 23 The CD4+ T cells are also preferentially depleted in the thymus and LN (Fig. 2F and Table 1 ). Efficient HIV-1 infection is also detected with R5-tropic JRCSF and X4-tropic NL4-3 in DKO-hu HSC mice ( Table 1 ).
The DKO-hu HSC mouse will serve as a relevant HIV-1 infection and pathogenesis model. 
